| scholarly article | Q13442814 |
| P50 | author | Eliezer Masliah | Q28324209 |
| P2093 | author name string | T Saitoh | |
| D Schubert | |||
| H Ninomiya | |||
| J M Roch | |||
| D A Otero | |||
| L W Jin | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Amyloid beta (A4) precursor protein | Q14865884 |
| neurite | Q1534415 | ||
| P304 | page(s) | 5461-5470 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension | |
| P478 | volume | 14 |
| Q90654725 | A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes |
| Q39739662 | A macromolecular complex involving the amyloid precursor protein (APP) and the cytosolic adapter FE65 is a negative regulator of axon branching |
| Q24674865 | A novel mechanism for the regulation of amyloid precursor protein metabolism |
| Q35021238 | A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein |
| Q36318872 | ACAT1 regulates the dynamics of free cholesterols in plasma membrane which leads to the APP-α-processing alteration |
| Q36840033 | APP Receptor? To Be or Not To Be. |
| Q39533342 | APP and APLP1 are degraded through autophagy in response to proteasome inhibition in neuronal cells. |
| Q52047052 | APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons. |
| Q51976713 | Abnormalities in cellular adhesion of neuroblastoma and fibroblast models of Lesch Nyhan syndrome. |
| Q38857243 | Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease |
| Q42519345 | Age-dependent differential regulation of genes encoding APP and alpha-synuclein in hippocampal synaptic plasticity |
| Q34328562 | Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain |
| Q34142269 | Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization |
| Q70913702 | Amyloid precursor protein (APP) expression in multiple sclerosis lesions |
| Q46048319 | Amyloid precursor protein activates phosphotyrosine signaling pathway |
| Q38678160 | Amyloid precursor protein in pancreatic islets. |
| Q41060779 | Amyloid precursor protein potentiates the neurotrophic activity of NGF. |
| Q42263336 | Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain |
| Q48516393 | Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity |
| Q39724489 | Amyloid-β precursor protein induces glial differentiation of neural progenitor cells by activation of the IL-6/gp130 signaling pathway |
| Q52173135 | Antisense approach for study of cell adhesion molecules in central nervous system. |
| Q42450952 | Apolipoprotein e4 decreases whereas apolipoprotein e3 increases the level of secreted amyloid precursor protein after closed head injury |
| Q41042072 | Changes in morphology of neuroblastoma cells treated with all-trans retinoic acid combined with transfer of the C-terminal region of the amyloid precursor protein |
| Q40503541 | Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy |
| Q53233837 | Choline plus cytidine stimulate phospholipid production, and the expression and secretion of amyloid precursor protein in rat PC12 cells. |
| Q27674231 | Crystal structure of amyloid precursor-like protein 1 and heparin complex suggests a dual role of heparin in E2 dimerization |
| Q26829183 | Curcuminoids and resveratrol as anti-Alzheimer agents |
| Q28589908 | Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2 |
| Q48291087 | Dinucleotide deletions in neuronal transcripts: a novel type of mutation in non-familial Alzheimer's disease and Down syndrome patients. |
| Q48559543 | Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata |
| Q34582070 | Effects of acetylate hyperforin on the processing of amyloid precursor protein |
| Q31090524 | Evidence for binding of the ectodomain of amyloid precursor protein 695 and activated high molecular weight kininogen |
| Q53327691 | Expression and analysis of heparin-binding regions of the amyloid precursor protein of Alzheimer's disease. |
| Q35889911 | From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells |
| Q33796184 | Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein |
| Q48461559 | Increased expression of amyloid precursor protein and amyloid precursor-like protein 2 during trophic factor withdrawal-induced death of neuronal PC12 cells |
| Q28478681 | Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker |
| Q26999922 | Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease |
| Q35904068 | Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease. |
| Q51731926 | Knockout of Amyloid β Protein Precursor (APP) Expression Alters Synaptogenesis, Neurite Branching and Axonal Morphology of Hippocampal Neurons. |
| Q94554883 | Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson's disease |
| Q48404361 | Mutations in RNA: a first example of molecular misreading in Alzheimer's disease |
| Q37987144 | Physiological functions of APP family proteins |
| Q36962319 | Potential role of PCTAIRE-2, PCTAIRE-3 and P-Histone H4 in amyloid precursor protein-dependent Alzheimer pathology |
| Q33760959 | Progress toward valid transgenic mouse models for Alzheimer's disease |
| Q35850787 | Proteins that bind to the RERMS region of beta amyloid precursor protein |
| Q38929253 | Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease. |
| Q46614690 | Reversible ischemia increases levels of Alzheimer amyloid protein precursor without increasing levels of mRNA in the rabbit spinal cord |
| Q39242927 | SILAC-based proteomic analysis to investigate the impact of amyloid precursor protein expression in neuronal-like B103 cells |
| Q48538138 | Secreted amyloid precursor protein alpha selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP. |
| Q33988005 | Secreted human amyloid precursor protein binds semaphorin 3a and prevents semaphorin-induced growth cone collapse. |
| Q34776047 | Soluble alpha-APP (sAPPalpha) regulates CDK5 expression and activity in neurons |
| Q35072706 | Soluble β-amyloid Precursor Protein Alpha binds to p75 neurotrophin receptor to promote neurite outgrowth |
| Q33254880 | Stroke-induced subventricular zone proliferation is promoted by tumor necrosis factor-alpha-converting enzyme protease activity |
| Q42177260 | Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis |
| Q64105372 | Targeting the Iron-Response Elements of the mRNAs for the Alzheimer's Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity |
| Q36293844 | The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement |
| Q26864818 | The Beta-amyloid protein of Alzheimer's disease: communication breakdown by modifying the neuronal cytoskeleton |
| Q27667862 | The E2 Domains of APP and APLP1 Share a Conserved Mode of Dimerization |
| Q26750116 | The Neuroprotective Properties of the Amyloid Precursor Protein Following Traumatic Brain Injury |
| Q24306930 | The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo |
| Q41758596 | The amyloid precursor protein gene: a neuropeptide gene with diverse functions in the central nervous system |
| Q28587197 | The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity |
| Q42119567 | The chick as a model for the study of the cellular mechanisms and potential therapies for Alzheimer's disease |
| Q35027419 | The effect of a secreted form of beta-amyloid-precursor protein on intracellular Ca2+ increase in rat cultured hippocampal neurones |
| Q27026919 | The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes |
| Q74552056 | The role of glycoproteins in neural development function, and disease |
| Q41753871 | The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration? |
| Q42822424 | The secreted form of the Alzheimer's beta-amyloid precursor protein stimulates a membrane-associated guanylate cyclase |
| Q47073605 | The zebrafish amyloid precursor protein-b is required for motor neuron guidance and synapse formation |
| Q40915146 | Transfected human B cells: a new model to study the functional and immunostimulatory consequences of APP production |
| Q43284371 | Transgenic expression of human wild-type amyloid precursor protein decreases neurogenesis in the adult hippocampus |
| Q21202832 | Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease? |
| Q35170198 | What can rodent models tell us about cognitive decline in Alzheimer's disease? |
| Q33838961 | What the evolution of the amyloid protein precursor supergene family tells us about its function |
Search more.